Literature DB >> 35836888

Effect of care intervention based on susceptible pointers of care quality in patients with hepatic cerebropathy.

Lina Chen1, Suyu Rao1, Shuyu Fan1, Chenwei Pan1, Minou Liu1, Liyun Yi1, Junyi Guo1.   

Abstract

OBJECTIVE: To investigate the effect of care intervention based on susceptible pointers of care quality in patients with hepatic cerebropathy.
METHODS: The clinical data of 106 patients with hepatic cerebropathy from January 2020 to June 2021 were retrospectively analyzed, and they were assigned to a study group (n=53) or a control group (n=53) in line with diverse care means. The control group received conventional care, and the study group received additional care intervention based on susceptible pointers of care quality. The liver function, blood ammonia, neural function, capacity of daily life, and quality of life were observed and contrasted in the two groups before and after the intervention. The implementation or occurrence of key indicators of care quality, the occurrence of adverse care events, and patient care satisfaction rate were documented in the two groups after intervention.
RESULTS: After the intervention, the liver function, neural function, capacity of everyday activities, quality of life and the implementation or occurrence of key pointers of care quality in the study group were superior to those in the control group (P<0.05). The blood ammonia and the incidence of adverse events in the study group were lower than those of the control group (P<0.05), and the care satisfaction rate of patients in the study group was higher than that of the control group (P<0.05).
CONCLUSION: Care intervention based on susceptible pointers of care quality can help patients with hepatic cerebropathy to enhance liver and neural function, decrease blood ammonia and have fewer adverse care events, and enhances quality of life, care quality, and care satisfaction of patients. AJTR
Copyright © 2022.

Entities:  

Keywords:  Susceptible pointers of care quality; care effect; care intervention; care satisfaction rate; hepatic cerebropathy; impact

Year:  2022        PMID: 35836888      PMCID: PMC9274580     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  17 in total

1.  Fostering leadership competence and satisfaction in nursing undergraduates through a student-led conference: A quasi-experimental pre-post study.

Authors:  M A De Juan Pardo; P Fuster; A Gallart; E Rodríguez; L Wennberg; M L Martin-Ferreres
Journal:  Nurse Educ Today       Date:  2021-01-18       Impact factor: 3.442

2.  Exploring the incidence and nature of nursing-sensitive orthopaedic adverse events: A multicenter cohort study using Global Trigger Tool.

Authors:  Ami Hommel; Martin Magnéli; Bodil Samuelsson; Kristina Schildmeijer; Desirée Sjöstrand; Katarina E Göransson; Maria Unbeck
Journal:  Int J Nurs Stud       Date:  2019-11-13       Impact factor: 5.837

3.  Successful treatment of recurrent hepatic encephalopathy with revision of transjugular intrahepatic portasystemic shunt and embolisation of splenorenal shunt.

Authors:  Padmini Krishnamurthy; Ammar Ahmad
Journal:  BMJ Case Rep       Date:  2021-06-24

4.  The effects of thymoquinone on memory impairment and inflammation in rats with hepatic encephalopathy induced by thioacetamide.

Authors:  Somayeh Hajipour; Alireza Sarkaki; Mahin Dianat; Mohammad Rashno; Laaya Sadat Khorsandi; Yaghoob Farbood
Journal:  Metab Brain Dis       Date:  2021-02-23       Impact factor: 3.584

Review 5.  Polyethylene glycol versus lactulose in the treatment of hepatic encephalopathy: a systematic review and meta-analysis.

Authors:  Gilles Jadd Hoilat; Mohamad Fekredeen Ayas; Judie Noemie Hoilat; Ahmed Abu-Zaid; Ceren Durer; Seren Durer; Talal Adhami; Savio John
Journal:  BMJ Open Gastroenterol       Date:  2021-05

6.  Comparing the Japanese Version of the Ocular Surface Disease Index and Dry Eye-Related Quality-of-Life Score for Dry Eye Symptom Assessment.

Authors:  Takenori Inomata; Masahiro Nakamura; Masao Iwagami; Akie Midorikawa-Inomata; Yuichi Okumura; Keiichi Fujimoto; Nanami Iwata; Atsuko Eguchi; Hurramhon Shokirova; Maria Miura; Kenta Fujio; Ken Nagino; Shuko Nojiri; Akira Murakami
Journal:  Diagnostics (Basel)       Date:  2020-04-07

Review 7.  Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment.

Authors:  Ramzi Hassouneh; Jasmohan S Bajaj
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

8.  Nursing-sensitive quality indicators for pernicious placenta previa in obstetrics: A Delphi study based across Chinese institutions.

Authors:  Meng Zhang; Weiping Chen; Cuiping Liu; Jing Sui; Dawei Wang; Yan Wang; Xin Meng; Yiqian Wang; Chongyu Yue
Journal:  Nurs Open       Date:  2021-05-07

9.  Deep hyperammonemic hepatic encephalopathy precipitated by fecal microbiota transplantation for fulminant Clostridioides difficile infection.

Authors:  Lotte Lindgreen Eriksen; Simon Mark Dahl Baunwall; Peter Lykke Eriksen; Kirstine Petrea Bak-Fredslund; Jens Erik Nielsen; Jens Frederik Dahlerup; Karen Louise Thomsen; Hendrik Vilstrup; Christian Lodberg Hvas
Journal:  Gastroenterol Rep (Oxf)       Date:  2021-10-15

10.  Preoperative risk factors associated with new focal neurological deficit and other major adverse events in first-time intracranial meningioma neurosurgery.

Authors:  Freya Sophie Jenkins; Flavio Vasella; Luis Padevit; Valentino Mutschler; Kevin Akeret; Julia Velz; Luca Regli; Johannes Sarnthein; Marian Christoph Neidert
Journal:  Acta Neurochir (Wien)       Date:  2021-07-14       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.